Joint Venture: 2021 Updates in Rheumatoid Arthritis

Jason Liebowitz, MD, completed his fellowship in rheumatology at Johns Hopkins University, Baltimore, where he also earned his medical degree. He is currently in practice with Skylands Medical Group, N.J.

References

1. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021 Jul;73(7):924–939.
2. Jain S, Dhir V, Aggarwal A, Gupta R, et al. Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: A multicentre, parallel group, randomised controlled trial. Ann Rheum Dis. 2021 Nov;80(11):1376–1384.
3. George MD, Hsu JY, Hennessy S, et al. Risk of serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: An instrumental variable analysis. 2021 Sep 20.
4. Burmester GR, Buttgereit F, Bernasconi C, et al. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): A double-blind, multicentre, randomised controlled trial. Lancet. 2020 Jul 25;396(10246):267–276.